You Position: Home > Paper
Expression of SFRP2 and β-catenin in the carcinogenesis and progression of colorectal Carcinoma
( views:243, downloads:8 )
- Author:
- No author available
- Journal Title:
- WORLD CHINESE JOURNAL OF DIGESTOLOGY
- Issue:
- 35
- DOI:
- 10.3969/j.issn.1009-3079.2008.35.007
- Key Word:
- 大肠癌;SFRP2;β-catenin;表达
Abstract： 目的:探讨分泌型Frizzled相关蛋白2(Secreted Frizzled-related proteins 2,SFRP2)和β-连接素(β-catenin)在大肠癌发生、发展中的作用.方法:采用免疫组化SP法检测20例正常大肠黏膜、加例非腺瘤性息肉、36例大肠腺瘤和42例大肠癌组织中的SFRP2和β-catenin蛋白的表达情况,分析二者表达的差异及其与临床病理参数的关系.结果:大肠癌和大肠腺瘤组SFRP2的阳性表达率显著低于正常大肠黏膜和非腺瘤性息肉组(28.57% VS 100.0%,95.0%;36.11% VS 100.0%,95.0%,均P＜0.05);大肠癌中β-catenin膜表达缺失率显著高于正常大肠黏膜、非腺瘤性息肉及大肠腺瘤组(52.4% VS 0%,0%,11.1%,均P＜0.05);大肠癌和大肠腺瘤组β-catenin异位表达率显著高于正常大肠黏膜和非腺瘤性息肉组(64.3% VS 0%,0%;30.6% VS 0%,0%,均P＜0.05),大肠癌β-catenin异位表达率高于大肠腺瘤(P＜0.05);SFRP2表达、β-catenin膜表达缺失及异位表达与大肠癌患者的肿瘤部位、大体形态、肿瘤直径、淋巴转移和Dukes分期无明显关系,而与大肠癌的分化程度密切相关,其中SFRP2表达还与大肠癌的浸润深度密切相关:SFRP2表达与β-catenin膜表达缺失、异位表达均呈明显负相关(r=-0.452,P=0.003;r=-0.519,P=0.000),而β-catenin膜表达缺失与异位表达呈明显正相关(r=0.782,P=0.000).结论:SFRP2和β-catenin的表达与大肠癌的发生、发展密切相关,可能是大肠癌发生的早期事件,且SFRP2表达与β-catenin膜表达缺失、异位表达均呈负相关,前者起抑癌作用,后者起促癌作用.
- [1]Jian Qi,You-Qing Zhu,Jun Luo,etc.Hypermethylation and expression regulation of secreted frizzled-related protein genes in colorectal tumor[J].2006,(44).
- [2]王双双,关景明,范玉晶.大肠癌发病的相关因素[J].2005,(4).
- [3]顾国利,魏学明,王石林,等.大肠癌E-cadherin,β-catenin,MMP-7表达及其临床意义[J].2007,(4).
- [4]马思平,单吉贤,王辉.E-cadherin和β-catenin在大肠癌组织中的表达及与预后的关系[J].2003,(4).
- [5]Zhao-hui HUANG,Li-hua Li,FAN Yang,etc.Detection of aberrant methylation in fecal DNA as a molecular screening tool for colorectal cancer and precancerous lesions[J].2007,(6).
- [6]于敏,李姝玉,于湛,等.肝素酶和碱性成纤维细胞生长因子与非小细胞肺癌转移和预后的关系[J].2005,(1).
- [7]Dao-Rong Wang,Dong Tang.Hypermethylated SFRP2 gene in fecal DNA is a high potential biomarker for colorectal cancer noninvasive screening[J].2008,(4).
- [8]ZHANG Yun-gang,DU Juan,TIAN Xin-xia,etc.Expression of E-cadherin, beta-catenin, cathepsin D, gelatinases and their inhibitors in invasive ductal breast carcinomas[J].2007,(18).
- [9]Suzuki H,Masuda N,Shimura T.Nuclear beta-catenin expression at the invasive front and in the vessels predicts liver metastasis in colorectal carcinoma.[J].2008,28(3B).
- [10]Kirchner T,Brabletz T,Jung A.Beta-catenin and the morphogenesis of colorectal cancer.[J].2002,441(1).
- [11]Nosho K,Kawasaki T,Meyerhardt JA,etc.Correlation of beta-catenin localization with cyclooxygenase-2 expression and CpG island methylator phenotype (CIMP) in colorectal cancer.[J].2007,9(7).
- [12]A, Bànkfalvi,H J, Terpe,D, Breukelmann,etc.Immunophenotypic and prognostic analysis of E-cadherin and beta-catenin expression during breast carcinogenesis and tumour progression: a comparative study with CD44.[J].1999,34.
- [13]Autier P,Heanue M,Boniol M,etc.Estimates of the cancer incidence and mortality in Europe in 2006.[J].2007,18(3).
- [14]Xu J,Murray T,Siegel R,etc.Cancer statistics, 2007.[J].2007,57(1).
- [15]Lustig B,Behrens J.The Wnt connection to tumorigenesis[J].2004,48(5).
- [16]El-Tanani MK,O'Connell A,Johnston PG,etc.The role of LEF/TCF factors in neoplastic transformation.[J].2008,8(1).
- [17]Giles RH,Clevers H,van Es JH.Caught up in a Wnt storm: Wnt signaling in cancer.[J].2003,1653(1).
- [18]Kawano Y.,Kypta R..Secreted antagonists of the Wnt signalling pathway[J].2003,116(13).
- [19]Paul S,Dey A.Wnt signaling and cancer development: therapeutic implication.[J].2008,55(3).
- [20]K-I, Takemaru,M, Ohmitsu,F-Q, Li.An oncogenic hub: beta-catenin as a molecular target for cancer therapeutics.[J].2008,(186).
- [21]Bordonaro M,Lazarova DL,Sartorelli AC.Hyperinduction of Wnt activity: a new paradigm for the treatment of colorectal cancer?[J].2008,17(10).
- [22]Zitt M,Margreiter R,Fiegl H,etc.SFRP2 methylation in fecal DNA-a marker for colorectal polyps.[J].2008,23(1).
- [23]Morris LesleyS,Miller Richard,Freeman Alex,etc.Analysis of minichromosome maintenance proteins as a novel method for detection of colorectal cancer in stool.[J].2002,359(9321).
- [24]Suzuki H,Weijenberg MP,Van Engeland M,etc.A genomic screen for genes upregulated by demethylation and histone deacetylase inhibition in human colorectal cancer.[J].2002,31(2).
- [25]Suzuki H,Imai K,Markowitz SD,etc.Epigenetic inactivation of SFRP genes allows constitutive WNT signaling in colorectal cancer.[J].2004,36(4).
- [26]Maruyama K,Ochiai A,Akimoto S,etc.Cytoplasmic beta-catenin accumulation as a predictor of hematogenous metastasis in human colorectal cancer.[J].2000,59(4).
- [27]Jayanthi V,Devaraj N,Udhayakumar G,etc.Interaction of MUC1 with beta-catenin modulates the Wnt target gene cyclinD1 in H. pylori-induced gastric cancer.[J].2007,46(9).
- [28]Syrjanen K,Elzagheid A,Collan Y,etc.Nuclear beta-catenin expression as a prognostic factor in advanced colorectal carcinoma.[J].2008,14(24).
- [29]Aaronson SA,Bafico A,Goldin L,etc.An autocrine mechanism for constitutive Wnt pathway activation in human cancer cells.[J].2004,6(5).